IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

LUBRANO DI SCORPANIELLO, Ennio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.075
EU - Europa 5.499
AS - Asia 965
AF - Africa 366
SA - Sud America 122
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 14
Totale 13.061
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.023
IE - Irlanda 1.955
UA - Ucraina 532
IT - Italia 485
FI - Finlandia 447
SG - Singapore 398
RU - Federazione Russa 382
CN - Cina 371
AT - Austria 363
CI - Costa d'Avorio 349
DE - Germania 349
SE - Svezia 321
FR - Francia 266
GB - Regno Unito 235
BR - Brasile 92
IN - India 52
CA - Canada 41
BE - Belgio 34
NL - Olanda 34
TR - Turchia 24
LT - Lituania 18
AU - Australia 17
IR - Iran 15
VN - Vietnam 15
EU - Europa 14
IL - Israele 12
ES - Italia 11
KZ - Kazakistan 11
CO - Colombia 9
CZ - Repubblica Ceca 9
HR - Croazia 8
CL - Cile 7
JP - Giappone 7
PL - Polonia 7
RO - Romania 7
AZ - Azerbaigian 6
CH - Svizzera 6
EG - Egitto 6
GR - Grecia 6
MY - Malesia 6
AR - Argentina 5
MX - Messico 5
PA - Panama 5
HK - Hong Kong 4
IQ - Iraq 4
KG - Kirghizistan 4
LV - Lettonia 4
MA - Marocco 4
PE - Perù 4
PH - Filippine 4
PK - Pakistan 4
PT - Portogallo 4
TH - Thailandia 4
UZ - Uzbekistan 4
BD - Bangladesh 3
BG - Bulgaria 3
DK - Danimarca 3
EC - Ecuador 3
ID - Indonesia 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
ZA - Sudafrica 3
BO - Bolivia 2
BY - Bielorussia 2
KR - Corea 2
NO - Norvegia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
IM - Isola di Man 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
NG - Nigeria 1
SC - Seychelles 1
Totale 13.061
Salva come PNG Salva come JPEG
Città #
Dublin 1.955
Jacksonville 1.319
Chandler 1.133
Wilmington 409
Vienna 361
Abidjan 349
Helsinki 305
Rome 266
Houston 248
San Mateo 247
Singapore 199
Ann Arbor 185
Princeton 179
Woodbridge 146
Boardman 143
Dearborn 94
Los Angeles 83
Ashburn 66
Beijing 65
New York 44
Redwood City 41
Moscow 36
Mountain View 36
Molise 34
Dallas 33
Brussels 31
Jinan 27
Amsterdam 23
Frankfurt am Main 23
London 22
Milan 19
Nanjing 19
Falls Church 17
Guangzhou 16
Shenyang 16
Shanghai 15
Toronto 15
Ningbo 14
Auburn Hills 13
Leawood 13
Ottawa 13
Augusta 12
Haikou 12
Ardabil 10
Dong Ket 10
Nuremberg 10
Seattle 10
Borås 9
Chicago 9
Norwalk 9
Rockville 9
São Paulo 9
Taizhou 9
Zhengzhou 9
Changsha 8
Esslingen am Neckar 8
Grenoble 8
Manchester 8
Taiyuan 8
Hefei 7
Monmouth Junction 7
Olomouc 7
Tianjin 7
Almaty 6
Baku 6
Detroit 6
Fairfield 6
Lappeenranta 6
Nanchang 6
Simi Valley 6
Astana 5
Chennai 5
Falkenstein 5
Kunming 5
San Francisco 5
Shenzhen 5
St Louis 5
Tappahannock 5
Warsaw 5
Athens 4
Berlin 4
Bishkek 4
Bogotá 4
Chongqing 4
Fleet 4
Fuzhou 4
Greenford 4
Hangzhou 4
Hebei 4
Istanbul 4
Jiaxing 4
Manila 4
Qingdao 4
Quzhou 4
Renton 4
Riga 4
Santa Clara 4
Tashkent 4
Ariccia 3
Bangkok 3
Totale 8.636
Salva come PNG Salva come JPEG
Nome #
An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment 128
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting 114
Measuring psoriatic disease in clinical practice. An expert opinion position paper. 109
Venous thrombophilia in a patient with protein S deficiency, factor V Leiden and homozygous MTHFR C -> T677 mutation 106
Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study 103
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. 102
Validity and reliability of an Italian version of the revised Leeds disability questionnaire for patients with ankylosing spondylitis 102
Validity, responsiveness and feasibility of an Italian version of the Canadian Occupational Performance Measure for patients with ankylosing spondylitis 102
Iperuricemia e rischio cardio-renale 102
Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors 101
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients 99
Supervised training and home-based rehabilitation in patients with stabilized ankylosing spondylitis on TNF inhibitor treatment: a controlled clinical trial with a 12-month follow-up 98
La spondilodiscite delle spondiloartriti sieronegative 96
Pharmacoeconomic burden in the treatment of psoriatic arthritis: from systematic reviews to real clinical practice studies 96
Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions 95
The arthritis of coeliac disease: prevalence and pattern in 200 adult patients 94
Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study 94
Pharmacoeconomic issues in psoriatic arthritis 92
Simple clinical indicators for early psoriatic arthritis detection. 92
Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis 92
Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients 91
Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report 91
Validity of the modified stoke ankylosing spondylitis spine score (M-SASSS) and of the bath ankylosing spondylitis radiology index (BASRI) for the radiological assessment of axial involvement in psoriatic arthritis. multicentre validation study. Part one. 89
Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate 89
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study 89
Venous thrombophilia with severe mesenteric involvement associated to homozygosity for factor V Leiden and heterozygosity for G20210A mutation of prothrombin 88
Subcorneal pustular dermatosis (Sneddon-Wilkinson syndrome): another cutaneous manifestation of SAPHO syndrome? 88
Trauma and seronegative spondylarthropathy 87
The performance of CASPAR criteria in early psoriatic arthritis - preliminary results from an Italian prospective multicentric study 87
Patient education in psoriatic arthritis: a cross sectional study on knowledge by a validated self-administered questionnaire 87
Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: A cross-sectional analysis of a longitudinal cohort 87
Unmet Needs in Axial Spondyloarthritis 87
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 87
Etanercept in psoriatic arthritis 87
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study 86
Assessment of subclinical atherosclerosis in ankylosing spondylitis: Correlations with disease activity indices 86
Treatment options: NSAIDs and DMARDs 85
Secukinumab for ankylosing spondylitis and psoriatic arthritis 85
An audit of anthropometric measurements by medical and physiotherapy staff in patients with ankylosing spondylitis 84
Unmet needs in outcome measures of Psoriatic Arthritis: focus on axial radiographic and nail involvement 84
Can traditional disease-modifying anti-rheumatic drugs be withdrawn or tapered in psoriatic arthritis? 84
The arthritis of ulcerative colitis: clinical and genetic aspects 84
Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: A systematic review. 84
Consensus on the management of patients with psoriatic arthritis in a dermatology setting 84
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings 84
Latent tuberculosis infection detection and active tuberculosis prevention in patients receiving anti-TNF therapy: an Italian nationwide survey. 83
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications 83
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis. 82
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs 82
Defining low disease activity states in psoriatic arthritis using novel composite disease instruments 82
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis 82
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy 82
An overview of low disease activity and remission in psoriatic arthritis. 81
The role of IL-17 in the treatment of psoriatic arthritis 81
Updated guidelines for the management of axial disease in psoriatic arthritis 81
Qualifying Unmet Needs and Improving Standards of Care in Psoriatic Arthritis. 80
Axonal degeneration in systemic sclerosis can be reverted by factors improving tissue oxygenation 80
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 80
ANTHROPOMETRIC MEASUREMENTS AND DISABILITY IN A OPEN FOLLOW UP STUDY ON ANKYLOSING SPONDYLITIS WITH COMBINED MEDICAL AND REHABILITATIVE TREATMENT 79
Predictors of loss of remission and disease flares in patients with axial spondyloarthritis receiving antitumor necrosis factor treatment: A retrospective study 79
Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis 78
Aortic involvement in ankylosing spondylitis 78
The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept 78
Beyond early diagnosis: occult psoriatic arthritis 77
Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study. 77
The assessment of knowledge in ankylosing spondylitis patients by a self-administered questionnaire 77
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study 77
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 76
Somatic perception in irritable bowel syndrome (IBS) patients with and without fibromyalgia (FMS). Does the severity of IBS influence the perception of somatic stimuli? 76
Antiphospholipid syndrome, activated protein C resistance and mutation C -> T 677 in the MTHFR gene with juvenile pulmonary embolism. A case report 76
Psoriatic disease: Clinical staging 76
Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis 75
Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model 75
Is the Nail Psoriasis Severity Index reliable in the assessment of nail psoriasis by rheumatologists? 75
The effectiveness of rehabilitation in active ankylosing spondylitis assessed by the ASAS response criteria 75
A novel biological target for the treatment of psoriatic arthritis. 74
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection. 73
Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients. 73
L’educazione del paziente affetto da artrite reumatoide. 73
Subcutaneous anti-TNF alfa induced sustained minimal disease activity and remission in psoriatic arthritis patients: a retrospective study 73
Multimorbidity and comorbidity in psoriatic arthritis–a perspective 73
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis. 72
The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods. 72
Physical trauma triggers psoriasis in a patient with undifferentiated seronegative spondyloarthropathy 72
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). 71
Emerging drugs for psoriatic arthritis 71
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review 71
Juvenile rheumatoid arthritis, Crohn's disease and Turner's syndrome: a novel association 70
Reverse correlation between extent of colon involvement and number of affected joints in patients with ulcerative colitis and arthritis 70
Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis 70
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices 70
Patient's global assessment as an outcome measure for psoriatic arthritis in clinical practice: A surrogate for measuring low disease activity? 70
Outcome measures in psoriatic arthritis 69
Assessment of psoriatic nail disease activity by rheumatologists 69
Psoriatic Arthritis and Psoriasis Projects in Italy: A Report from the GRAPPA 2011 Meeting 69
New insights in occult psoriatic arthritis 69
New approaches in tumor necrosis factor antagonism for the treatment of psoriatic arthritis: Certolizumab pegol 68
Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs 68
Psoriatic arthritis: imaging techniques 67
Fibromyalgia is strongly associated with the severity of inflammatory bowel syndrome. 67
Totale 8.308
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.023
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020970 0 0 0 0 0 54 280 94 215 91 54 182
2020/20211.591 27 178 9 243 273 102 199 20 206 17 266 51
2021/2022968 51 252 16 31 55 28 29 106 141 154 43 62
2022/20234.660 535 121 102 392 245 377 16 220 2.328 144 82 98
2023/2024850 237 132 54 20 30 72 18 47 19 46 84 91
2024/20251.778 456 120 430 92 543 137 0 0 0 0 0 0
Totale 13.474